These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decoding multiple sclerosis: an update on genomics and future directions. Oksenberg JR Expert Rev Neurother; 2013 Dec; 13(12 Suppl):11-9. PubMed ID: 24289837 [TBL] [Abstract][Full Text] [Related]
3. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080 [TBL] [Abstract][Full Text] [Related]
4. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869 [TBL] [Abstract][Full Text] [Related]
5. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771 [TBL] [Abstract][Full Text] [Related]
6. The immunogenetics of multiple sclerosis: A comprehensive review. Hollenbach JA; Oksenberg JR J Autoimmun; 2015 Nov; 64():13-25. PubMed ID: 26142251 [TBL] [Abstract][Full Text] [Related]
7. Current gene-mapping strategies in experimental models of multiple sclerosis. Becanovic K; Jagodic M; Wallström E; Olsson T Scand J Immunol; 2004; 60(1-2):39-51. PubMed ID: 15238072 [TBL] [Abstract][Full Text] [Related]
8. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Roeske D; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F J Neuroimmunol; 2010 Oct; 227(1-2):162-6. PubMed ID: 20598377 [TBL] [Abstract][Full Text] [Related]
9. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048 [TBL] [Abstract][Full Text] [Related]
15. Power of the affected-sib-pair method to defect disease susceptibility loci of small effect: an application to multiple sclerosis. Suarez B; O'Rourke D; Van Eerdewegh P Am J Med Genet; 1982 Jul; 12(3):309-26. PubMed ID: 6956238 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561 [TBL] [Abstract][Full Text] [Related]
17. [New gene map for multiple sclerosis]. Harbo HF; Lorentzen AR; Lie BA; Celius EG; Spurkland A Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2126-30. PubMed ID: 22048209 [TBL] [Abstract][Full Text] [Related]
18. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503 [TBL] [Abstract][Full Text] [Related]
19. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility. Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574 [TBL] [Abstract][Full Text] [Related]